Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02141633 · ClinicalTrials.gov registry record · NA
Airway and Pulmonary Vascular Endothelial Function in Healthy Smokers: Effect of Inhaled Glucocorticosteroid Treatment
A NA study, sponsored by University of Miami.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT02141633 is a NA study that has completed, run by University of Miami. The registered enrollment target is 31 participants.
The verdict
NCT02141633, a NA study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
The purposes of the present proposal are to 1) compare inhaled albuterol-induced changes in airway blood flow (Qaw), and in CO and Ppas in healthy current smokers and lifetime non-smokers as an index of endothelial function in the airway and pulmonary circulations, 2) compare the results between smokers and non-smokers, and 3) determine the effect of a 4-week treatment with an ICS on albuterol responsiveness of Qaw and the echocardiographic parameters. With this protocol the Investigators will test the hypotheses that a) there is a correlation between airway and pulmonary vascular endothelial function within the current smoker and non-smoker groups, and b) ICS treatment improves airway and pulmonary vascular endothelial function in the current smoker group.
Interventions
- DRUG placebo
- DRUG Fluticasone propionate
- PROCEDURE echocardiogram plus albuterol
- PROCEDURE airway blood flow plus albuterol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2013-04 |
| Est. Completion | 2015-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02141633
The ClinicalTrials.gov registry entry for NCT02141633 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which placebo is the first listed.
NCT02141633 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02141633 about?
NCT02141633 is a clinical study titled "Airway and Pulmonary Vascular Endothelial Function in Healthy Smokers: Effect of Inhaled Glucocorticosteroid Treatment". The purposes of the present proposal are to 1) compare inhaled albuterol-induced changes in airway blood flow (Qaw), and in CO and Ppas in healthy current smokers and lifetime non-smokers as an index of endothelial function in the airway and pulmonary circulations, 2) compare the results between smo...
What is the current status of trial NCT02141633?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2013-04. Estimated completion is 2015-12.
What interventions are being tested in trial NCT02141633?
The interventions under investigation include: placebo (DRUG), Fluticasone propionate (DRUG), echocardiogram plus albuterol (PROCEDURE), airway blood flow plus albuterol (PROCEDURE).
Who is sponsoring clinical trial NCT02141633?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.